The Age of Outbreaks (1934-1959)
The modern history of ME/CFS begins with a series of institutional cluster outbreaks documented between 1934 and 1959. Fourteen epidemics across four continents shared a remarkably consistent phenotype: acute onset with flu-like prodrome, neurological involvement (muscle weakness, sensory disturbance, cognitive dysfunction), profound and prolonged fatigue, and negative results on every standard laboratory test available at the time (Acheson 1959). Female predominance, prolonged convalescence measured in months to years, and a tendency for healthcare workers to be overrepresented (likely reflecting exposure intensity rather than occupational susceptibility) were consistent features across all outbreaks.
1 Los Angeles County Hospital, 1934
The first documented ME/CFS outbreak occurred at Los Angeles County Hospital in 1934, affecting 198 staff members (Gilliam 1938). Symptoms mimicked poliomyelitis — muscle pain, paresis, sensory disturbances — but all polio tests were negative. The United States Public Health Service investigated and classified the illness as “atypical poliomyelitis,” establishing a pattern that would repeat for decades: outbreaks recognized as neurological but categorized by exclusion of known pathogens rather than positive identification of a new disease entity. Recovery was prolonged; many staff never returned to work.
2 Iceland and Akureyri Disease (1948–1949)
The 1948-49 Akureyri, Iceland outbreak affected 1,106 people and gave the disease one of its early names: “Iceland disease” (Sigurdsson et al. 1950). Like the Los Angeles outbreak, it presented with neurological features, profound fatigue, and prolonged recovery. Diagnostic testing for known pathogens was negative. Sigurdsson classified it as a distinct neurological disorder and described a triphasic course — acute phase with flu-like symptoms, a subacute phase with neurological manifestations, and a chronic phase of persistent fatigue and cognitive dysfunction — a pattern that remains central to clinical descriptions today.
3 Adelaide and Other 1949–1953 Clusters
The 1949 Adelaide outbreak in South Australia and subsequent clusters in New York State (1950), Middlesex (1952), Coventry and Rockville (1953) expanded the geographic range (Acheson 1959). Each cluster shared the same features — acute febrile onset, neurological involvement, prolonged fatigue, negative standard testing — and each was recorded as a distinct local phenomenon rather than instances of the same recurring disease. The absence of a shared nomenclature prevented recognition of the pattern.
4 The Royal Free Epidemic, London 1955
The Royal Free Hospital outbreak in 1955 became the defining event of the early ME/CFS period. Between July and November, 292 medical and nursing staff fell ill with a syndrome characterized by severe muscle pain, paresis, sensory disturbances, emotional lability, vertigo, and profound fatigue (Medical Staff of the Royal Free Hospital 1957). The outbreak forced partial closure of the hospital. Laboratory investigations — CSF analysis, virology, serology — found nothing abnormal: a result that would be repeated across every subsequent outbreak and, in 2024, be vindicated by the NIH deep phenotyping study showing that standard clinical laboratory panels remain normal even in molecularly confirmed ME/CFS.
The Royal Free epidemic gave the disease its enduring name: “myalgic encephalomyelitis” (ME), introduced by the hospital’s medical staff in their 1957 BMJ report. The term captured the cardinal features — myalgia (muscle pain), encephalo- (brain involvement), myel- (spinal cord involvement), -itis (inflammation) — though the suffix proved controversial, as histological evidence of CNS inflammation was not demonstrated at autopsy.
5 Acheson’s Synthesis, 1959
E.D. Acheson published a landmark 1959 review that synthesized all 14 known epidemics worldwide into a single clinical entity (Acheson 1959). Acheson coined “benign myalgic encephalomyelitis” — “benign” intended to distinguish it from poliomyelitis (which killed or paralyzed), though the word would later be recognized as deeply misleading given the life-altering disability ME produces. Ramsay, who had personally examined Royal Free patients during the 1955 outbreak, later published long-term follow-up documentation that validated Acheson’s synthesis. The 1959 synthesis established ME as a recognizable, recurring clinical syndrome with a consistent phenotype across continents and decades.